Genscript Biotech Redesignates Dr. Grossman as Independent Director

Story Highlights
Genscript Biotech Redesignates Dr. Grossman as Independent Director

Genscript Biotech ( (HK:1548) ) has provided an announcement.

Genscript Biotech Corporation has announced the redesignation of Dr. Ross Allen Grossman from a non-executive Director to an independent non-executive Director, effective March 11, 2025. This change in the board’s composition reflects the company’s strategic focus on strengthening its governance structure, potentially enhancing its industry positioning and stakeholder confidence.

More about Genscript Biotech

Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotechnology sector. The company, along with its subsidiaries, focuses on providing innovative solutions in the biotech industry.

YTD Price Performance: 13.39%

Average Trading Volume: 3,834

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $3.72B

For detailed information about 1548 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App